GlassScriptPhysician profile
James William Walter
NPI 1083903314
$37,884.02
in general payments reported to CMS, 2019-2025
18 companies · $15K in 2025
The $15K reported for 2025 was more than what 94% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $30.77 · 2021: $53.15 · 2022: $9,863 · 2023: $5,743 · 2024: $7,226 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Honoraria: $9,347 · Travel and Lodging: $4,049 · Food and Beverage: $2,744.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,654.50 |
| Honoraria | $9,346.50 |
| Travel and Lodging | $4,049.15 |
| Food and Beverage | $2,743.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $13,033.87 | 2021-2025 | Gi Genius, Interstim |
| Eli Lilly and Company | $12,907.85 | 2023-2025 | Omvoh |
| Celltrion USA INC. | $10,514.66 | 2024-2025 | Zymfentra, Vegzelma |
| Abbvie INC. | $550.96 | 2019-2025 | Skyrizi, Linzess, Viberzi |
| Takeda Pharmaceuticals U.S.A., INC. | $199.40 | 2019-2025 | Entyvio, Eohilia |
| Janssen Biotech, INC. | $169.31 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| E.R. Squibb & Sons, L.L.C. | $145.25 | 2023 | Zeposia |
| Aimmune Therapeutics, INC. | $125.00 | 2023 | |
| Lilly USA, LLC | $59.11 | 2024-2025 | Omvoh |
| Ardelyx, INC. | $45.09 | 2025 | Ibsrela |
| Boston Scientific Corporation | $33.81 | 2023 | Spyglass, Extractor Pro Rx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.83 | 2022 | |
| Pfizer INC. | $16.73 | 2025 | |
| Exact Sciences Corporation | $16.16 | 2023 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $16.03 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $14.74 | 2020 | |
| Intercept Pharmaceuticals, INC. | $14.22 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.